35453299|t|SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells.
35453299|a|Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the loss of motor neurons in the brain and spinal cord. While the exact causes of ALS are still unclear, the discovery that familial cases of ALS are related to mutations in the Cu/Zn superoxide dismutase (SOD1), a key antioxidant enzyme protecting cells from the deleterious effects of superoxide radicals, suggested that alterations in SOD1 functionality and/or aberrant SOD1 aggregation strongly contribute to ALS pathogenesis. A new scenario was opened in which, thanks to the generation of SOD1 related models, different mechanisms crucial for ALS progression were identified. These include excitotoxicity, oxidative stress, mitochondrial dysfunctions, and non-cell autonomous toxicity, also implicating altered Ca2+ metabolism. While most of the literature considers motor neurons as primary target of SOD1-mediated effects, here we mainly discuss the effects of SOD1 mutations in non-neuronal cells, such as glial and skeletal muscle cells, in ALS. Attention is given to the altered redox balance and Ca2+ homeostasis, two processes that are strictly related with each other. We also provide original data obtained in primary myocytes derived from hSOD1(G93A) transgenic mice, showing perturbed expression of Ca2+ transporters that may be responsible for altered mitochondrial Ca2+ fluxes. ALS-related SOD1 mutants are also responsible for early alterations of fundamental biological processes in skeletal myocytes that may impinge on skeletal muscle functions and the cross-talk between muscle cells and motor neurons during disease progression.
35453299	0	4	SOD1	Gene	20655
35453299	8	11	ALS	Disease	MESH:D000690
35453299	91	120	Amyotrophic lateral sclerosis	Disease	MESH:D000690
35453299	122	125	ALS	Disease	MESH:D000690
35453299	138	164	neurodegenerative disorder	Disease	MESH:D019636
35453299	264	267	ALS	Disease	MESH:D000690
35453299	324	327	ALS	Disease	MESH:D000690
35453299	388	392	SOD1	Gene	20655
35453299	469	479	superoxide	Chemical	MESH:D013481
35453299	520	524	SOD1	Gene	20655
35453299	555	559	SOD1	Gene	20655
35453299	595	598	ALS	Disease	MESH:D000690
35453299	677	681	SOD1	Gene	20655
35453299	731	734	ALS	Disease	MESH:D000690
35453299	778	792	excitotoxicity	Disease	
35453299	812	838	mitochondrial dysfunctions	Disease	MESH:D028361
35453299	864	872	toxicity	Disease	MESH:D064420
35453299	899	903	Ca2+	Chemical	-
35453299	990	994	SOD1	Gene	20655
35453299	1051	1055	SOD1	Gene	20655
35453299	1133	1136	ALS	Disease	MESH:D000690
35453299	1190	1194	Ca2+	Chemical	-
35453299	1343	1347	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;OriginalGene:20655;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:10090;CA#:257327
35453299	1360	1364	mice	Species	10090
35453299	1466	1470	Ca2+	Chemical	-
35453299	1479	1482	ALS	Disease	MESH:D000690
35453299	1491	1495	SOD1	Gene	20655
35453299	Association	MESH:D028361	20655
35453299	Association	MESH:D000690	20655

